Selected article for: "ARDS treatment and cytokine storm"
Author: Kloc, Malgorzata; Ghobrial, Rafik M.
Title: The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
  • Cord-id: w6274bdg
  • Document date: 2020_7_31
    • ID: w6274bdg
    Snippet: We encourage studies on the effectiveness of multiple sclerosis drugs for the treatment of ARDS in COVID-19 infection. These drugs, through the inhibition of the RhoA/actin-dependent expression of virus receptors in the macrophages and macrophage recruitment to the lungs, have the potential to inhibit cytokine storm of long macrophages, reduce or eliminate ARDS and improve the outcome of COVID-19 infection.
    Document: We encourage studies on the effectiveness of multiple sclerosis drugs for the treatment of ARDS in COVID-19 infection. These drugs, through the inhibition of the RhoA/actin-dependent expression of virus receptors in the macrophages and macrophage recruitment to the lungs, have the potential to inhibit cytokine storm of long macrophages, reduce or eliminate ARDS and improve the outcome of COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lung failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
    • acute ards respiratory distress syndrome and lung macrophage: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute ards respiratory distress syndrome and lung tissue damaging: 1
    • acute ards respiratory distress syndrome and macrophage infiltration: 1, 2
    • acute ards respiratory distress syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and macrophage receptor: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and macrophage recruitment: 1
    • acute ards respiratory distress syndrome and macrophage response: 1, 2, 3, 4, 5
    • lung epithelial cell and macrophage monocyte: 1
    • lung epithelial cell and macrophage recruitment: 1
    • lung failure and macrophage response: 1
    • lung macrophage and macrophage infiltration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • lung macrophage and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • lung macrophage and macrophage receptor: 1, 2, 3
    • lung macrophage and macrophage receptor expression: 1, 2, 3
    • lung macrophage and macrophage recruitment: 1, 2, 3, 4, 5
    • lung macrophage and macrophage response: 1, 2, 3, 4, 5, 6, 7, 8